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Available online 10 July 2016The 2009 Family Smoking Prevention and Tobacco Control Act opened the possibility for tobacco companies to
apply tomarket their products as having “modiﬁed” or reduced risks. However, research on how to communicate
comparative tobacco risks and how such messages are interpreted is limited. This study aimed to qualitatively
examine perceptions of potential modiﬁed risk statements presented as warning labels for e-cigarettes. We con-
ducted six focus groups between 2014 and 2015 with 27 adult e-cigarette users and cigarette-only smokers who
provided comments on two versions of amodiﬁed riskwarning for e-cigarettes: 1) “WARNING: No tobacco prod-
uct is safe, but this product presents substantially lower risks to health than cigarettes” (as proposed by two com-
panies for their smokeless tobacco products) and 2) “WARNING: This product may be harmful to health, but is
substantially less harmful than cigarettes” (an alternative developed by our team). Althoughmost personally be-
lieved that e-cigarettes are safer than cigarettes and some thought the messages were true and accurate, many
were skeptical and uncomfortable with the warnings because they did not “seem like a warning” and because
use of the phrase “substantially lower risks” could be misleading and difﬁcult to understand. Several thought
the second warning was stronger (e.g., more active, more speciﬁc). Modiﬁed risk messages about e-cigarettes
may impact perceptions and use of the product. More research is needed to identify the framing, wording and
placement (e.g. within or in addition to a warning) that could potentially increase population-level beneﬁts
and minimize harms.
© 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Keywords:
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Tobacco1. Introduction
There is a growing recognition that different tobacco products pose
different levels of risk to individual users (Fiore et al., 2014; Royal
College of Physicians, 2007; Zeller and Hatsukami, 2009; Zeller, 2013)
and some have advocated that the public should be better informed of
these comparative risks (Kiviniemi and Kozlowski, 2015; Kozlowski
and Edwards, 2005; O'Connor et al., 2007; Pepper et al., 2015). This is
important given that health behavior theories (e.g., Theory of Planned
Behavior, Health Belief Model) suggest that individuals' knowledge
and beliefs about tobacco products, whichmay include risk perceptions,
may predict use of those products (Glanz et al., 2015). Indeed, longitu-
dinal studies have shown signiﬁcant relationships between lower to-
bacco risk perceptions at baseline and product use or experimentation
at follow-up (Choi and Forster, 2014; Song et al., 2009a; Song et al.,
2009b; Villanti et al., 2015). In its assumption of regulatory authority
over tobacco products through the 2009 Tobacco Control Act, the Food
and Drug Administration (FDA) opened the possibility for tobacco com-
panies to apply for permission to market their products as having. This is an open access article undermodiﬁed-risks (U.S. Food and Drug Administration, 2012). This applica-
tion should include evidence that suchmarketing could reduce harm in
smokers who switch to them, without simultaneously introducing
population-level harm that outweighs this potential beneﬁt, such as
product uptake by non-tobacco users, including youth.
To date, two tobacco companies (Reynolds American Inc. and Swed-
ishMatch) have petitioned the FDA to change the wording of a warning
label on their smokeless tobacco products (“This product is not a safe al-
ternative to cigarettes”) to read that “No tobacco product is safe but this
product presents substantially lower risks to health than cigarettes”
(U.S. Food and Drug Administration, 2015a). Reynolds American Inc.
(RAI) requested this under a “Citizen Petition” (denied in May 2015)
(U.S. Food and Drug Administration, 2015b) while Swedish Match
ﬁled a modiﬁed-risk tobacco product (MRTP) application. During an
April 2015 review, the Tobacco Products Scientiﬁc Advisory Committee
(TPSAC) to the FDA voted against the warning change, with members
noting, among various concerns, inadequate research on the
statement's development and consumers' perceptions and understand-
ing of it (U.S. Food and Drug Administration, 2015a). However the FDAthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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livered a ruling, which could be granted as indicated in the application,
granted with some conditions (e.g., some labeling disclosures), or
denied.
With the FDA's regulatory authority now extended to e-cigarettes, it
is possible that similar modiﬁed-risk statements could be proposed for
e-cigarettes, given that they are also regarded as posing reduced risks
compared to combusted cigarettes (Pepper et al., 2015; Public Health
England, 2015; Wackowski et al., 2016a). However, as with smokeless
tobacco products, very limited research on this topic exists. One exper-
imental study of non-smokers found that seeing ads with the RAI/SM
reduced-risk message lowered perceived harm for moist snuff, but not
snus or e-cigarettes (Popova and Ling, 2014). We aimed to contribute
to this limited knowledge base by qualitatively examining perceptions
of potential modiﬁed-risk warnings for e-cigarettes.
2. Materials and methods
Results are from a larger focus group study on perceptions of poten-
tial e-cigarette warning statements. Six focus groups (targeted for 5–6
participants each) were conducted with a convenience sample of New
Jersey adults between December 2014 and January 2015. Three groups
were conducted with adult current e-cigarette users (i.e., smokers or
former smokers who have used e-cigarettes for more than 1 day in
the last 30 days) and three with adult current cigarette smokers
(i.e., have ever smoked 100 cigarettes and now smoke every day or
some days)whomayhave ever tried e-cigarettes butwere not currently
active users (referred to from here on as “non-e-cigarette users”).
Participants discussed their perceptions about six draft warning
statements. These referred to e-cigarettes as being potentially addictive,
poisonous, containing toxins, having unknown health effects, unap-
proved for smoking cessation, and not safe alternatives to cigarettes. Re-
sults of these are presented elsewhere (Wackowski, 2016b).
Afterwards, participants commented on two versions of a modiﬁed-
risk message for e-cigarettes, presented in the style of a warning:
1) “WARNING: No tobacco product is safe, but this product presents
substantially lower risks to health than cigarettes” (as proposed by
RAI and SM) and 2) “WARNING: This productmay be harmful to health,
but is substantially less harmful than cigarettes” (an alternative mes-
sage developed by our team). The presentation order of these was ran-
domized across groups. Reactions to thesewarnings are the focus of this
report.
Participants were debriefed, given a smoking cessation resource
sheet and a $50 gift card after the session. Transcripts were coded
with Atlas.ti qualitative software, using codes developed deductively a
priori and inductively based on themes identiﬁed from repeated tran-
script readings. Coded text was then re-reviewed to summarize major
themes and select illustrative participant quotes (in some cases edited
for brevity and clarity). This study was approved by the Rutgers Univer-
sity Institutional Review Board.
3. Results
Most participants (n=27)weremale (67%),white (63%) and had at
least some college or technical school education (74%). Non-white par-
ticipants were black (14.8%), Asian (14.8%) or of other race (7.4%). Cur-
rent e-cigarette users (n = 14) were younger on average (27 years)
than the non-user participants (40 years) (age range, 19–58). All of
the non-e-cigarette users were current smokers and most (77%) were
daily smokers who intended to quit in the next six months (77%) and
had tried e-cigarettes (84.6%). Among current e-cigarette users, 57%
still smoked tobacco cigarettes every day or somedays. On average,
these dual users used e-cigarettes on 21 of the last 30 days. The rest of
the current e-cigarette userswere former smokerswho nowexclusively
used e-cigarettes (an average of 29 of the past 30 days).3.1. Overall perceptions of reduced risk statements
There was general understanding among participants that both ver-
sions of the reduced-risk statements conveyed that e-cigarettes are not
necessarily safe, but are safer than regular cigarettes. Most also ap-
peared to agree that the phrase “substantially lower risks” meant that
e-cigarettes are safer, and some speciﬁcally noted that it meant e-
cigarettes present “a lot less” risks to health than regular cigarettes.
Two e-cigarette users quantiﬁed “substantially lower” as meaning
“more than half” and two other e-cigarette users thought it suggested
that “You might not get cancer” from using e-cigarettes, and that the
risks are “obviously” lower.
Participants across all groups also agreed that the statements would
make e-cigarettes seem appealing, particularly to smokers, and would
likely encourage their use (Table 1, Section A). Several e-cigarette
users, agreed that the reduced-risk messages were “true” and “accu-
rate,” and what they wanted to hear.
However, several participants, including current and non-e-
cigarette users, commented that themessages didn't “seem like awarn-
ing” and/or that they felt more like e-cigarette advertisements (Table 1,
Section B) and did not really warn about any speciﬁc risks (Table 1,
Section C). One e-cigarette/cigarette dual user explained that the mes-
sageswould not be appropriate as a “SurgeonGeneralwarning” because
“it would deﬁnitely have to say if it has some kind of actual health risk
like cancer or anything like that,” but that such information could be
“a good thing to put on, like, maybe the box that it comes in.”
Althoughmanyparticipants personally believed that e-cigarettes are
safer than regular cigarettes, they nevertheless appeared somewhat
skeptical and uncomfortable with the reduced-risk statements aswarn-
ings because the actual risks of e-cigarettes are still unknown. These
sentiments were expressed in both exclusive and dual e-cigarette/
cigarette users. At least some of this concern was directly related to
the statements' use of the phrasing “substantially lower risks,” which
some participants did not believe had been clearly established yet and
could be misleading (Table 2, Section D). For some, the phrase also
made them wonder how much lower the risks were speciﬁcally, and
how such differences were known/measured. Participants also noted
that some people, including younger and less educated people, may
not know or understand the word “substantially.” One participant ad-
mitted himself that: ‘I don't know the exact deﬁnition of substantially.
I am not stupid but I just don't know” (male, non-e-cigarette user, age
31).3.2. Message comparisons
While participants initially indicated that the two versions of the
reduced-risk statements were very similar (same idea, different
words) some perceived differences were revealed upon discussion.
Across groups, some participants felt that use of the word “may” in
the “may be harmful to health” warning suggested uncertainty
about whether e-cigarettes are harmful at all, making it weaker
than the “No tobacco product is safe” phrase. However, many partic-
ipants across groups appeared to ﬁnd the “harmful” statement to be
a stronger warning overall and to be less favorable towards e-
cigarettes, particularly when asked about changing the phrasing
from “may be harmful” to “is harmful.” Some participants appeared
to think that the harmful statement was stronger because it felt
less like an advertisement, more speciﬁcally communicated about
e-cigarettes (rather than tobacco products in general), and/or more
actively communicated that e-cigarettes may cause harm (Table 2).
Lastly, while one person thought the “No tobacco product is safe”
statement was stronger because it connected e-cigarettes to “tobac-
co”which is known to be harmful, others thought this language was
inappropriate for an e-cigarette because they did not view it as being
a tobacco product.
Table 1
Select example quotes of participants' perceptions of proposed reduced risk statements,a,b
by theme.
A. Perceptions that proposed reduced risk statements would make e-cigarettes seem
appealing and likely encourage their use
• “It makes it sound a whole lot better…like ‘okay yeah, all right, if it's that much
less harmful I might as well check it out.’” (female non-e-cigarette user, age 49)
• “…I think a lot of younger people would see this and be like ‘oh well, I don't
really smoke but it's not as bad as cigarettes so why not start this?’…And
that's why warning labels that commend the product aren't really you know,
present…” (male exclusive e-cigarette user, age 19)
B. Perceptions that proposed reduced risk statements don't seem like a warning or
are not appropriate as a warning
• “It just seems like a sales pitch for electronic cigarettes to me…” (male non-e-
cigarette user, age 29)
• “Yeah, it's not um – it doesn't seem like a warning…This is more advisory than
warning…” (male non-e-cigarette user, age 39)
• “This is like saying, ‘Hey buy me, take me home,’…as a warning I would say,
it's looking pretty positive for somebody that wants to move on to an e-
-cigarette.” (female non-e-cigarette user, age 58)
• “I think it's good marketing, but not for a warning label.” (male exclusive
e-cigarette user, age 31)
• “I don't think they should be legally allowed to put this until you can tell me
the health risks.” (female exclusive e-cigarette user, age 33)
• “I feel like that's what the companies want to put on their label.” (male dual
e-cigarette/cigarette user, age 23)
• “…that's like an advertisement kind of…” (male dual e-cigarette/cigarette
user, age 20)
C. Perceptions that proposed reduced risk statements were too general, did not warn
about any speciﬁc risks
• “Yeah well this is just uh like a broad warning I guess, so they're not going in
depth about what's in the product…It's more like ‘hey we made this, it's not safe
but you can trust us that it's better than cigarettes.’” (male exclusive e-cigarette
user, age 23),
• “You're gonna tell me it's bad for my health. Why? Am I gonna turn it over and
see the woman going [holds hand up to throat in suggestion of a stoma]. You
know so like what am I talking about here?” (female exclusive e-cigarette
user, age 33)
• “…Cause I wanna know what is it gonna do, you know? How is it gonna be
harmful to me? …Because we know what cigarettes can do to people, you
know, we see the commercials with the lady with the hole in her throat… is
e-cigs gonna do this to me or is it just…I donno, you know?” (female dual
e-cigarette/cigarette user, age 26)
• “Yeah well I mean, no tobacco product is safe…That's like… everybody knows
that.” (female non-e-cigarette user, age 49)
• “It's too simple, it's saying ‘okay it's harmful but less harmful.’ It’s telling me
something but not enough…I mean we kinda knew that.” (female non-e-
cigarette user, age 49)
D. Skepticism about use of term “substantially lower risks”
• “My ﬁrst thought with that was ‘prove it.’ Because we don't know. We don't
know exactly how much healthier it is….with the words ‘substantially less
harmful,’ it could give certain people the thought ‘oh well this one can't give me
cancer so… game on.’ Um, when that's not necessarily accurate….” (female
exclusive e-cigarette user, age 33)
• “We haven't studied it yet. We don't know if it's substantially lower. I mean I
could almost probably guarantee that it's lower but substantially is a very
vague term… You can't say that. The FDA's not gonna let you put that on a
label because they don't…[know that]…” (male dual e-cigarette/cigarette, age
20)
• “And yes, there is like lower risk than cigarettes. But the whole ‘substantially,’
I'm like ‘ehhhhhhh’. It's a little iffy.” (male dual e-cigarette/cigarette, age 19)
• “I feel like if you put this on a label then I could sue you in 10 years. Cause you
said I can't get lung cancer cause it's substantially lower. Guess what, I got lung
cancer.” (female exclusive e-cigarette user, age 33)
• “…we don't know…So they can't say that it is [substantially less harmful]…
but what happens 15 years from now?” (male exclusive e-cigarette user, age
31)
• “There has to be some research behind the… to be able to put substantially
down.” (male exclusive e-cigarette user, age 53)
• “…that ‘substantially’ could be anybody's level. I mean how are they measur-
ing that? People want to know more, they are going to investigate that be-
cause that can mean just about anything.” (male non-e-cigarette user, age 32)
Note: within each section of table, quotes presented are from unique individuals.
a “WARNING: No tobacco product is safe, but this product presents substantially lower
risks to health than cigarettes”.
b “WARNING: This product may be harmful to health, but is substantially less harmful
than cigarettes”.
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This is the ﬁrst qualitative study on perceptions of modiﬁed-risk
warnings for a tobacco product, ﬁnding mixed feelings about them
among consumers. Although most believed e-cigarettes are safer thanTable 2
Select example quotes of participants' perceptions that the “more harmful” statementa
was stronger than the “not safe”modiﬁed risk statementb.
• “Because is harmful is more effective than ‘no tobacco product is safe’, everybody
knows that already and they don't care…It is smoother and it is more direct.”
(male non-e-cigarette user, age 32)
• “This second one [Harmful statement] jumped out at me…was stronger than the
ﬁrst one [Not Safe statement]…because it's telling me that it is, it is harmful to
your health…whereas the ﬁrst one is saying it's substantially… it's not telling
me that.” (female non-e-cigarette user, age 57)
• “It is saying that it is harmful, it is letting us know for sure it is harmful… There
is no doubt to it that it is going to hurt you, it is going to put a damper on your
health.” (female non-e-cigarette user, age 50)
• “Same message, different wording. But for the second one, it just…the second
one kind of speaks to me more. It's a little more effective. Um, it seems like less
of a sales pitch uh than the ﬁrst one, only because of wording.” (male non-e-
cigarette user, age 29)
• “…this one saying ‘no tobacco product is safe’- it is talking about regular ciga-
rettes but this one is saying ‘this product may be harmful to your health’, this is
talking directly about e-cigarettes. So I feel like this one [Harmful statement] is
speciﬁcally talking about e-cigarettes more than this one [Not Safe].” (male
non-e-cigarette user, age 19)
• “Yeah, it's [Not Safe statement] not saying that it's gonna be harmful to your
health like the other one is [harmful statement]. This is just saying ‘no tobacco is
safe, but this one's better for you!’” (female non-e-cigarette user, age 58)
• “I think message 7 [Not Safe statement] is it's almost like they're trying to sway
you like ‘hey listen nothing's really safe out there, but we've got some good stuff
that's not so bad.’ …where I feel like 7a [Harmful statement] is actually talking
about your health… It's becoming more speciﬁc…” (female exclusive e-cigarette
user, age 33)
• “This [Not Safe statement] just does sound like it's saying ‘hey buy this.’ But this
[Harmful statement] says ‘this is going to hurt you, but it's gonna hurt you less.’”
(male dual e-cigarette/cigarette user, age 19)
• “…it [Harmful statement] says that it's harmful to your health but it's less than…
I think that this one [Harmful statement] would make me think a little twice…
the one before it [Not Safe statement] I think was letting me know to buy it.”
(female dual e-cigarette/cigarette user, age 35)
Note: within each section of table, quotes presented are from unique individuals.
a “WARNING: This product may be harmful to health, but is substantially less harmful
than cigarettes”.
b “WARNING: No tobacco product is safe, but this product presents substantially lower
risks to health than cigarettes”.
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surprised by and uncomfortable with the messages in the form of a
“warning”, as they didn't actually warn about any particular risks, and
didn't “feel” like a warning. These ﬁndings were consistent with senti-
ments expressed during the TPSAC meeting on SM's MRTP application,
where several committee members supported the idea of communicat-
ing relative product risks but did not ﬁnd SM's proposed message to be
an appropriate standalone “warning” per se (U.S. Food and Drug
Administration, 2015a). Findings were also consistent with SM's con-
sumer perception study which found that respondents perceived the
proposed modiﬁed-risk warning to be signiﬁcantly less “believable”
than the existing smokeless tobacco warnings (U.S. Food and Drug
Administration, 2015a). More research on the degree to which a single
warning label could effectively and simultaneously communicate a
product's direct risk and relative risk to others is needed. These ﬁndings
might also suggest that reduced-riskmessagesmight bemore appropri-
ate in other formats, such as claims on advertisements, rather than in
warning labels. However, a recent study that examined reduced-risk
claims inmanipulated snus ads also found greater consumer skepticism
of these ads versus a control ad (Adkison et al., 2016), perhaps in part
because of a belief that they originated from the tobacco company.
Reduced-risk messages may play an important role in tobacco harm-
reduction, but more research is needed on their understanding, their
optimal placement and their potential impact (e.g., on risk perceptions,
source credibility, product initiation and use).
Our ﬁndings also point to the importance of wording and framing in
modiﬁed-risk messages. Even though both statements presented in-
cluded a modiﬁed-risk message, changing the “warning” in the ﬁrst
part of the statement from “no tobacco product is safe” to “this product
is harmful to health” seemed to make the overall statement somewhat
more credible and acceptable as a warning. Our ﬁndings with respect
to the statements' use of the term “substantially” point to potential pub-
lic interpretation problems when labels use vague descriptors, particu-
larly ones that assume high literacy (U.S. Food and Drug
Administration, 2015a). However, one potential alternative to this,
i.e., quantifying the degree of risk-reduction, is also complicated given
that such estimates may not be exactly known, can depend on product
type and use and be difﬁcult to understand, as suggested by literature
on innumeracy in risk communication (Nelson et al., 2009; Peters,
2008). More research into how reduced-risk tobacco information
should be communicated is important.
Study limitations included use of a small local convenience sample
which did not include non-smokers or youth, whom such messages
have potential to attract. Also, participants viewed these reduced-risk
statements after other more traditional proposed e-cigarette warnings,
which may have biased them to be more skeptical of such messages
then if they were presented ﬁrst or were the main focus of the study.
As alternative approaches to communicating tobacco-related harms
are examined (Kaufman et al., 2016), there is a need to identify mes-
sages and methods that both accurately communicate health risks and
convey modiﬁed risks of speciﬁc products. Our study provides insight
into the tensions between these two areas and the need for more re-
search on these topics. As any new reduced-riskmessages are deployed,
post-market surveillance will also be essential for monitoring how they
are interpreted and how theymight impact perceptions and behavior in
tobacco users and non-users.
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